Cost Of Sales Cambiamento Data
AbbVie USD 4.28B 90M 2023-12
Abbott USD 4.56B 49M 2023-12
Amgen USD 3.11B 1.31B 2023-12
AstraZeneca USD 2.06B 91M 2023-09
BioCryst Pharmaceuticals USD 1.14M 186K 2023-09
Bristol-Myers Squibb USD 2.71B 217M 2023-12
Eli Lilly USD 1.79B 72.1M 2023-12
GlaxoSmithKline GBP 2.24B 343M 2023-09
Incyte USD 64.05M 9.66M 2023-12
J&J USD 6.8B 418M 2023-12
Merck USD 3.34B 891M 2023-12
Nektar Therapeutics USD 12.43M 5.44M 2023-09
Pfizer USD 6.66B 2.24B 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
Takeda JPY 343.58B 22.47B 2023-09
TG Therapeutics USD 7.86M 4.35M 2023-12
Ultragenyx Pharmaceutical USD 12.05M 1.06M 2023-12



Karyopharm Therapeutics Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.